Anika Therapeutics Inc. (ANIK)
NASDAQ: ANIK
· Real-Time Price · USD
8.82
0.18 (2.08%)
At close: Aug 15, 2025, 3:40 PM
Anika Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 91.85M | 105.55M | 119.91M | 164.17M | 166.88M | 169.26M | 166.66M | 163.31M | 162.11M | 157.47M | 156.24M | 152.44M | 151.71M | 150.19M | 147.79M | 144.66M | 136.82M | 129.35M |
Cost of Revenue | 38.8M | 39.5M | 43.91M | 84.41M | 63.61M | 64.39M | 63.57M | 62.42M | 63.39M | 62.85M | 62.66M | 64.86M | 63.88M | 66.42M | 64.85M | 63.11M | 60.95M | 60.55M |
Gross Profit | 53.05M | 66.05M | 76M | 79.76M | 103.27M | 104.87M | 103.09M | 100.89M | 98.72M | 94.61M | 93.58M | 87.58M | 87.82M | 83.77M | 82.94M | 81.55M | 75.87M | 68.8M |
Operating Income | -8.66M | -4.32M | -5.1M | -34.51M | -14.17M | -17.96M | -25.45M | -30.52M | -28.65M | -28.4M | -19.4M | -21.86M | -14.76M | -2.2M | 2.62M | -6.21M | -15.44M | -34.16M |
Interest Income | 406K | 406K | 406K | 983K | 1.21M | 1.77M | 1.77M | 1.47M | 1.27M | 712K | 712K | 436K | n/a | n/a | n/a | 116K | 188K | 219K |
Pretax Income | -6.88M | -2.16M | -2.76M | -94.53M | -73.96M | -77.78M | -85.33M | -28.51M | -26.84M | -27.05M | -18.75M | -21.52M | -14.91M | -2.5M | 2.43M | -6.54M | -15.95M | -34.78M |
Net Income | -60.63M | -56.74M | -56.38M | -97.52M | -74.18M | -76.83M | -82.67M | -24.57M | -22.17M | -22.28M | -14.86M | -15.74M | -11.01M | -1.64M | 4.13M | -5.73M | -12.7M | -26.94M |
Selling & General & Admin | 39.36M | 46.93M | 55.55M | 80.78M | 86.5M | 90.38M | 95.85M | 98.56M | 95.01M | 92.59M | 84.79M | 82.18M | 78.4M | 75.12M | 74.1M | 68.84M | 67.25M | 63.81M |
Research & Development | 22.35M | 23.44M | 25.54M | 30.39M | 30.94M | 32.45M | 32.69M | 32.85M | 32.36M | 30.43M | 28.18M | 26.43M | 26.8M | 27.12M | 27.33M | 28.96M | 26.5M | 23.74M |
Other Expenses | n/a | n/a | n/a | 3.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 61.71M | 70.37M | 81.1M | 114.27M | 117.43M | 122.83M | 128.54M | 131.41M | 127.37M | 123.01M | 112.98M | 108.61M | 105.21M | 102.25M | 101.42M | 97.8M | 93.75M | 87.55M |
Interest Expense | 629K | n/a | 592K | 592K | 592K | 1.15M | 561K | 837K | 1.27M | 808K | 808K | 532K | 96K | n/a | n/a | 300K | 600K | 800K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 98.31M | 107.67M | 122.81M | 198.68M | 181.05M | 187.22M | 192.11M | 193.84M | 190.76M | 185.87M | 175.64M | 173.47M | 169.09M | 168.67M | 166.27M | 160.91M | 154.69M | 148.1M |
Income Tax Expense | 5.95M | 6.11M | 6.06M | 2.99M | 220K | -953K | -2.66M | -3.94M | -4.66M | -4.78M | -3.89M | -5.78M | -3.9M | -859K | -1.71M | -810K | -3.25M | -7.84M |
Shares Outstanding (Basic) | 14.33M | 14.3M | 14.58M | 14.77M | 14.84M | 14.7M | 14.65M | 14.63M | 14.69M | 14.58M | 14.64M | 14.4M | 14.21M | 14.47M | 14.37M | 14.43M | 14.39M | 14.34M |
Shares Outstanding (Diluted) | 14.33M | 14.3M | 14.72M | 14.77M | 14.84M | 14.7M | 14.65M | 14.63M | 14.69M | 14.65M | 14.64M | 14.6M | 14.55M | 14.47M | 14.44M | 14.65M | 14.63M | 14.44M |
EPS (Basic) | -4.15 | -3.88 | -3.85 | -6.65 | -5.07 | -5.25 | -5.65 | -1.69 | -1.53 | -1.54 | -1.03 | -1.09 | -0.76 | -0.11 | 0.29 | -0.41 | -0.9 | -1.89 |
EPS (Diluted) | -4.15 | -3.88 | -3.85 | -6.65 | -5.07 | -5.25 | -5.65 | -1.69 | -1.53 | -1.54 | -1.03 | -1.09 | -0.76 | -0.11 | 0.29 | -0.41 | -0.9 | -1.89 |
EBITDA | -5.84M | 633K | 1.45M | -23.09M | -1.8M | -4.1M | -11.23M | -16.22M | -14.39M | -13.98M | -4.91M | -6.48M | 1.07M | -229K | 966K | 2.97M | -2.55M | -3.22M |
EBIT | -7.18M | -6.42M | -6.61M | -94.53M | -74.59M | -78.98M | -87.06M | -30.52M | -28.65M | -28.4M | -19.4M | -21.9M | -14.85M | -2.34M | -2.35M | -11.02M | -16.05M | -34.68M |
Depreciation & Amortization | 3.62M | 7.27M | 8.28M | 10.44M | 12.29M | 14.38M | 15.33M | 15.99M | 15.92M | 13.93M | 12.46M | 12.3M | 12.32M | 14.17M | 16M | 15.41M | 14.93M | 14.62M |